AWA
EBS icon

Arkadios Wealth Advisors’s Emergent Biosolutions EBS Stock Holding History

Arkadios Wealth Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-428
Closed -$26K – 1912
2021
Q2 		$26K Sell
428
-31
-7% -$1.99K ﹤0.01% 1173
2021
Q1 		$42K Hold
459
– – 0.01% 735
2020
Q4 		$41K Buy
+459
New +$42.1K 0.01% 592

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Arkadios Wealth Advisors's EBS Position: Q3 2021 in Review

Arkadios Wealth Advisors sold out of Emergent Biosolutions (EBS) in Q3 2021, closing a stake of 428 shares — an estimated $26K sold.

Arkadios Wealth Advisors first reported a position in EBS in Q4 2020 and held it in 3 quarters. The position peaked at $42K in Q1 2021. 277 funds tracked by Wall St. Rank hold EBS as of Q3 2021.

  • Arkadios Wealth Advisors reported no remaining Emergent Biosolutions position as of Q3 2021 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 428 Emergent Biosolutions shares in Q3 2021, an estimated $26K.
  • Arkadios Wealth Advisors first reported a position in Emergent Biosolutions in Q4 2020 and held it in 3 quarters.
  • Arkadios Wealth Advisors's Emergent Biosolutions position peaked at $42K in Q1 2021.
  • 277 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2021.

Based on Arkadios Wealth Advisors's 13F filing for Q3 2021, filed 19 Oct 2021.